- Asian Markets Jump 2% as Credit Fears Ease
- Sanofi-Aventis to buy Primary Health unit
- Wall Street: What It's Looking For This Week
- Paulson: U.S. Banking System Fundamentally Sound
- Dow Chemical, Kuwait Petroleum Base Venture In Michigan
- "Dark Knight" Brightens Hollywood With Best Weekend Ever
- Tomato Growers: Damage From Salmonella Scare Devastating
- Fed's Stern: Hike Rates Sooner Rather Than Later
- Bank Stocks: Fear Trumps Fundamentals
- Web Extra: Your Earnings Edge And More
- Surprise Friday – Who Could It Be?
- The Latest Picks That Paid – Friday July 18th
- The Fast Money Misfires – Friday July 18th
- Pops & Drops: Intel, General Motors...
- The Future Of Wall Street
- Don’t Dump Everything Energy
- Can Apple Save Tech
- Kilduff: Iran Diplomacy = Lower Oil Prices?
Some sobering new statistics about the burgeoning Alzheimer's Disease epidemic.
An estimated 10 million baby boomers -- or one out of eight -- will get the disease according to a new report from the Alzheimer's Association.
It is now the seventh leading cause of death in the United States and the fifth leading cause among people 65 and older.
The Alzheimer's Association also says that 5.2 million Americans have the disease today and that another 10 million people are providing unpaid care to their loved ones.
Many drug and biotech companies are working on drugs to treat Alzheimer's. Wyeth [WYE Loading... ()] and Elan [ELN Loading... ()] are partners on a drug that's in late-stage development and should report major test results later this year.
Print
Email
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes